Skip to main content
MUTF:ETCHX

Eventide Healthcare & Life Sciences Fund CLASS C SHARES Stock Forecast, Price & News

$41.66
+0.23 (+0.56 %)
(As of 05/11/2021 12:00 AM ET)
Add
Today's Range
$41.66
$41.66
50-Day Range
$41.43
$49.64
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ETCHX News and Ratings via Email

Sign-up to receive the latest news and ratings for Eventide Healthcare & Life Sciences Fund CLASS C SHARES and its competitors with MarketBeat's FREE daily newsletter.


Headlines

Eventide Healthcare & Life Sciences Fund CLASS I SHARES
Eventide Healthcare & Life Sciences Fund CLASS I SHARES
July 30, 2020 |  markets.businessinsider.com
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc.
March 26, 2020 |  www.barrons.com
See More Headlines

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolMUTF:ETCHX
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Eventide Healthcare & Life Sciences Fund CLASS C SHARES (MUTF:ETCHX) Frequently Asked Questions

What stocks does MarketBeat like better than Eventide Healthcare & Life Sciences Fund CLASS C SHARES?

Wall Street analysts have given Eventide Healthcare & Life Sciences Fund CLASS C SHARES a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eventide Healthcare & Life Sciences Fund CLASS C SHARES wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Eventide Healthcare & Life Sciences Fund CLASS C SHARES's stock price been impacted by COVID-19 (Coronavirus)?

Eventide Healthcare & Life Sciences Fund CLASS C SHARES's stock was trading at $32.78 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ETCHX shares have increased by 27.1% and is now trading at $41.66.
View which stocks have been most impacted by COVID-19
.

What is Eventide Healthcare & Life Sciences Fund CLASS C SHARES's stock symbol?

Eventide Healthcare & Life Sciences Fund CLASS C SHARES trades on the MUTF under the ticker symbol "ETCHX."

How do I buy shares of Eventide Healthcare & Life Sciences Fund CLASS C SHARES?

Shares of ETCHX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eventide Healthcare & Life Sciences Fund CLASS C SHARES's stock price today?

One share of ETCHX stock can currently be purchased for approximately $41.66.


This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.